Paper Details 
Original Abstract of the Article :
Myocardon (1 tablet=0.5 mg Nitroglycerin, 100 mg Euphyllin, 29.7 mg Papaverin-hydrochlorid and 0.3 mg Atropinmethylnitrat, without phenobarbital) was given in a dosis of 3 and 6 tablets in patients with acute myocardial infarction. According to the initial value of left ventricular filling pressure ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://pubmed.ncbi.nlm.nih.gov/817116

データ提供:米国国立医学図書館(NLM)

Myocardon: A Potential Solution for Myocardial Infarction

In the heart of medical science, we're always seeking solutions for cardiovascular issues. This study explores the effectiveness of Myocardon, a drug containing nitroglycerin, in patients experiencing acute myocardial infarction. The researchers investigated its effect on patients with and without left ventricular failure. Their findings indicate that Myocardon, like a cool breeze in the desert, can help reduce pulmonary artery pressure and left ventricular filling pressure, potentially improving the condition of patients with acute myocardial infarction. The study also highlights the potential benefits of Myocardon in managing left ventricular failure.

Myocardon's Positive Impact on Heart Health

The results show that Myocardon can effectively reduce pulmonary artery pressure and left ventricular filling pressure in patients with acute myocardial infarction. These findings suggest that Myocardon could play a valuable role in managing this serious condition. In particular, the study indicates that Myocardon may be especially useful in patients with left ventricular failure, a condition that can significantly worsen the prognosis of a myocardial infarction.

Managing Myocardon's Side Effects

While the study indicates potential benefits, it's important to be aware of potential side effects, like a desert traveler always mindful of the risks. The researchers observed vomiting and sickness in a small number of patients. Careful monitoring and appropriate dosage adjustments are essential in treating patients with Myocardon.

Dr.Camel's Conclusion

This research offers a glimmer of hope for patients experiencing acute myocardial infarction. Myocardon, with its nitroglycerin component, demonstrates potential in reducing pressure and managing left ventricular failure. As with any medical treatment, it's crucial to approach it with caution and to carefully consider the potential benefits and risks.

Date :
  1. Date Completed 1976-07-06
  2. Date Revised 2013-11-21
Further Info :

Pubmed ID

817116

DOI: Digital Object Identifier

817116

SNS
PICO Info
in preparation
Languages

German

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.